A D Fisher1, G Senofonte2, C Cocchetti1, G Guercio3, V Lingiardi4, M C Meriggiola5, M Mosconi6, G Motta7, J Ristori1, A M Speranza4, M Pierdominici8, M Maggi9, G Corona10, F Lombardo11. 1. Andrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Viale Pieraccini 6, 50139, Florence, Italy. 2. Laboratory of Seminology, Sperm Bank "Loredana Gandini", Department of Experimental Medicine, Sapienza University of Rome, 00185, Rome, Italy. 3. Studio Legale Avv. Giovanni Guercio, Via Antonio Mordini, 14, 00195, Rome, Italy. 4. Department of Dynamic and Clinical Psychology, and Health Studies, Sapienza University of Rome, Via degli Apuli 1, 00185, Roma, Italy. 5. Gynecology and Physiopathology of Human Reproduction, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy. 6. Gender Identity Development Service, Hospital S. Camillo-Forlanini, Rome, Italy. 7. Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy. 8. Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy. 9. Department of Experimental, Clinical and Biomedical Sciences, Careggi University Hospital, Viale Pieraccini 6, 50139, Florence, Italy. 10. Endocrinology Unit, Medical Department, Maggiore-Bellaria Hospital, Azienda-Usl, Bologna, Italy. 11. Laboratory of Seminology, Sperm Bank "Loredana Gandini", Department of Experimental Medicine, Sapienza University of Rome, 00185, Rome, Italy. francesco.lombardo@uniroma1.it.
Abstract
PURPOSE: Gender Incongruence (GI) is a marked and persistent incongruence between an individual's experienced and the assigned gender at birth. In the recent years, there has been a considerable evolution and change in attitude as regards to gender nonconforming people. METHODS: According to the Italian Society of Gender, Identity and Health (SIGIS), the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE) rules, a team of experts on the topic has been nominated by a SIGIS-SIAMS-SIE Guideline Board on the basis of their recognized clinical and research expertise in the field, and coordinated by a senior author, has prepared this Position statement. Later on, the present manuscript has been submitted to the Journal of Endocrinological Investigation for the normal process of international peer reviewing after a first internal revision process made by the SIGIS-SIAMS-SIE Guideline Board. RESULTS: In the present document by the SIGIS-SIAMS-SIE group, we propose experts opinions concerning the psychological functioning, gender affirming hormonal treatment, safety concerns, emerging issues in transgender healthcare (sexual health, fertility issues, elderly trans people), and an Italian law overview aimed to improve gender non-conforming people care. CONCLUSION: In this Position statement, we propose experts opinions concerning the psychological functioning of transgender people, the gender-affirming hormonal treatment (full/partial masculinization in assigned female at birth trans people, full/partial feminization and de-masculinization in assigned male at birth trans people), the emerging issues in transgender health care aimed to improve patient care. We have also included an overview of Italian law about gender affirming surgery and registry rectification.
PURPOSE: Gender Incongruence (GI) is a marked and persistent incongruence between an individual's experienced and the assigned gender at birth. In the recent years, there has been a considerable evolution and change in attitude as regards to gender nonconforming people. METHODS: According to the Italian Society of Gender, Identity and Health (SIGIS), the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE) rules, a team of experts on the topic has been nominated by a SIGIS-SIAMS-SIE Guideline Board on the basis of their recognized clinical and research expertise in the field, and coordinated by a senior author, has prepared this Position statement. Later on, the present manuscript has been submitted to the Journal of Endocrinological Investigation for the normal process of international peer reviewing after a first internal revision process made by the SIGIS-SIAMS-SIE Guideline Board. RESULTS: In the present document by the SIGIS-SIAMS-SIE group, we propose experts opinions concerning the psychological functioning, gender affirming hormonal treatment, safety concerns, emerging issues in transgender healthcare (sexual health, fertility issues, elderly trans people), and an Italian law overview aimed to improve gender non-conforming people care. CONCLUSION: In this Position statement, we propose experts opinions concerning the psychological functioning of transgender people, the gender-affirming hormonal treatment (full/partial masculinization in assigned female at birth trans people, full/partial feminization and de-masculinization in assigned male at birth trans people), the emerging issues in transgender health care aimed to improve patient care. We have also included an overview of Italian law about gender affirming surgery and registry rectification.
Authors: Brian A Swiglo; M H Murad; Holger J Schünemann; Regina Kunz; Robert A Vigersky; Gordon H Guyatt; Victor M Montori Journal: J Clin Endocrinol Metab Date: 2008-01-02 Impact factor: 5.958
Authors: A D Fisher; G Castellini; J Ristori; H Casale; G Giovanardi; N Carone; E Fanni; M Mosconi; G Ciocca; E A Jannini; V Ricca; V Lingiardi; M Maggi Journal: J Endocrinol Invest Date: 2016-09-17 Impact factor: 4.256
Authors: Anna I R van der Miesen; Thomas D Steensma; Annelou L C de Vries; Henny Bos; Arne Popma Journal: J Adolesc Health Date: 2020-04-06 Impact factor: 5.012
Authors: Alessandra D Fisher; Elisa Bandini; Helen Casale; Naika Ferruccio; Maria C Meriggiola; Anna Gualerzi; Chiara Manieri; Emmanuele Jannini; Edoardo Mannucci; Matteo Monami; Niceta Stomaci; Augusto Delle Rose; Tommaso Susini; Valdo Ricca; Mario Maggi Journal: J Sex Med Date: 2012-11-21 Impact factor: 3.802
Authors: J V Gusmão-Silva; D C K Lichtenecker; L G A Ferreira; Í Gois; R Argeri; G N Gomes; M R Dias-da-Silva Journal: J Endocrinol Invest Date: 2022-06-11 Impact factor: 5.467
Authors: F Mazzoli; E Cassioli; J Ristori; G Castellini; E Rossi; C Cocchetti; A Romani; T Angotti; G Giovanardi; M Mosconi; V Lingiardi; A M Speranza; V Ricca; L Vignozzi; M Maggi; A D Fisher Journal: J Endocrinol Invest Date: 2022-07-02 Impact factor: 5.467